- Home
- AUPH vs VHI Comparison
AUPH vs VHI Comparison
Compare AUPH & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- VHI
- Stock Information
- Founded
- AUPH 1993
- VHI 1932
- Country
- AUPH Canada
- VHI United States
- Employees
- AUPH N/A
- VHI N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- VHI Major Chemicals
- Sector
- AUPH Health Care
- VHI Industrials
- Exchange
- AUPH Nasdaq
- VHI Nasdaq
- Market Cap
- AUPH 1.1B
- VHI 447.6M
- IPO Year
- AUPH 1999
- VHI N/A
- Fundamental
- Price
- AUPH $9.04
- VHI $17.99
- Analyst Decision
- AUPH Strong Buy
- VHI Sell
- Analyst Count
- AUPH 2
- VHI 1
- Target Price
- AUPH $11.50
- VHI $12.00
- AVG Volume (30 Days)
- AUPH 2.0M
- VHI 25.1K
- Earning Date
- AUPH 07-31-2025
- VHI 08-07-2025
- Dividend Yield
- AUPH N/A
- VHI 1.77%
- EPS Growth
- AUPH N/A
- VHI 4465.30
- EPS
- AUPH 0.27
- VHI 4.11
- Revenue
- AUPH $247,295,000.00
- VHI $2,112,800,000.00
- Revenue This Year
- AUPH $12.15
- VHI $22.20
- Revenue Next Year
- AUPH $18.34
- VHI $7.66
- P/E Ratio
- AUPH $34.04
- VHI $4.39
- Revenue Growth
- AUPH 29.20
- VHI 7.82
- 52 Week Low
- AUPH $5.20
- VHI $14.10
- 52 Week High
- AUPH $10.67
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- AUPH 64.76
- VHI 59.59
- Support Level
- AUPH $7.36
- VHI $18.15
- Resistance Level
- AUPH $9.10
- VHI $19.23
- Average True Range (ATR)
- AUPH 0.45
- VHI 0.89
- MACD
- AUPH 0.12
- VHI 0.13
- Stochastic Oscillator
- AUPH 96.69
- VHI 52.25
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.